JPAC Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee
  1. Home/
  2. Systematic Review Initiative/
  3. SRI Publications/
  4. Management of Anaemia

Management of Anaemia

  • Mo A, Poynton M, Wood E, Shortt J, Brunskill SJ, Doree C, Sandercock J, Saadah N, Luk E, Stanworth SJ, McQuilten Z.
    Do anemia treatments improve quality of life and physical function in patients with myelodysplastic syndromes (MDS)? A systematic review.
    Blood Reviews 2023;61:101114.
    Access abstract: PubMed / full text: Elsevier (freely available)

  • Neoh K, Page A, Chin-Yee N, Doree C, Bennett MI.
    Practice review: Evidence-based and effective management of anaemia in palliative care patients.
    Palliative Medicine. 2022;36(5):783-94
    Access abstract: PubMed / full text: PubMed Central (freely available)

  • Geneen LJ, Kimber C, Doree C, Stanworth S, Shah A.
    Efficacy and Safety of Intravenous Iron Therapy for Treating Anaemia in Critically ill Adults: A Rapid Systematic Review With Meta-Analysis.
    Transfusion Medicine Reviews. 2022;36(2):97-106.
    Access abstract: PubMed / full text: Elsevier (subscription required)

  • Shah AA, Donovan K, Seeley C, Dickson EA, Palmer AJR, Doree C, et al.
    Risk of Infection Associated With Administration of Intravenous Iron: A Systematic Review and Meta-analysis.
    JAMA Network Open. 2021;4(11):e2133935.
    Access abstract: PubMed / full text: PubMed Central (freely available)

  • Shah A, Fisher SA, Wong H, Roy NB, McKechnie S, Doree C, Litton E, Stanworth SJ.
    Safety and efficacy of iron therapy on reducing red blood cell transfusion requirements and treating anaemia in critically ill adults: A systematic review with meta-analysis and trial sequential analysis.
    Journal of Critical Care 2019;49:162-71.
    Access abstract: PubMed / full text: Elsevier (subscription required)

  • Shah A, Sugavanam A, Reid J, Palmer AJ, Dickson E, Brunskill S, Doree C, Oliver CM, Acheson A, Baikady RR, Bampoe S, Litton E, Stanworth S.
    Risk of infection associated with intravenous iron preparations: protocol for updating a systematic review.
    BMJ Open 2019;9(6):e024618.
    Access abstract: PubMed / full text: PubMed Central (freely available)

  • Shah A, Palmer AJR, Fisher SA, Rahman SM, Brunskill S, Doree C, Reid J, Sugavanam A, Stanworth SJ.
    What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis.
    Perioperative Medicine (London) 2018;7:30.
    Access abstract: PubMed / full text: PubMed Central (subscription required)

  • Shah A, Roy NB, McKechnie S, Doree C, Fisher SA, Stanworth SJ. 
    Iron supplementation to treat anaemia in adult critical care patients: a systematic review and meta-analysis. 
    Critical Care 2016;20(1):306.
    Access abstract: PubMed / full text: PubMed Central (freely available)
     
  • Wilson J, Yao GL, Raftery J, Bohlius J, Brunskill S, Sandercock J, Bayliss S, Moss P, Stanworth S, Hyde C.
    A systematic review and economic evaluation of epoetin alfa, epoetin beta and darbepoetin alfa in anaemia associated with cancer, especially that attributable to cancer treatment.
    Health Technology Assessment 2007 Apr;11(13):1-220.
    PMID: 17408534.
    Access abstract: PubMed / Executive Summary: PubMed Health (freely available)
     
  • Tinegate H, Brunskill S, Stanworth S.
    Recombinant human erythropoietins in patients with anaemia associated with cancer.
    Blood Matters 2007; Spring Issue 21: 9-11.
    Access full text: here (freely available)
     
  • Bohlius J, Wilson J, Seidenfeld J, Piper M, Schwarzer G, Sandercock J, Trelle S, Weingart O, Bayliss S, Djulbegovic B, Bennett C, Langensiepen S, Hyde C, Engert A.
    Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients.
    Journal of the National Cancer Institute 2006, 98(10):708-14.
    PMID: 16705125
    Access abstract: PubMed / full text: Oxford Journals (freely available)
     
  • Bohlius J, Wilson J, Seidenfeld J, Piper M, Schwarzer G, Sandercock J, Trelle S, Weingart O, Bayliss S, Brunskill S, Djulbegovic B, Bennett C, Langensiepen S, Hyde C, Engert A.
    Erythropoietin or darbepoetin for patients with cancer.
    Cochrane Database of Systematic Reviews, 2006;(3):CD003407.
    PMID: 16856007. doi: 10.1002/14651858.CD003407.pub5
    Access abstract: PubMed / full text: Wiley (subscription may be required)
     
  • Seidenfeld J, Piper M, Bohlius J, Weingart O, Trelle S, Engert A, Skoetz N, Schwarzer G, Wilson J, Brunskill S, Hyde C, Bonnell C, Zeigler KM, Aronson N.
    Comparative effectiveness of epoetin and darbepoetin for managing anaemia in patients undergoing cancer treatment.
    Comparative Effectiveness Review No. 3 (Prepared by Blue Cross and Blue Shield Association Technology Evaluation Center Evidence-based Practice Center under contract No. 290-02-0026). Rockville, MD: Agency for Healthcare Research and Quality, May 2006.
    Full paper available at: AHRQ Effective Health Care Program - Reports (PDF 1,544 KB)
     
  • Bohlius J, Wilson J, Bayliss S, Djulbegovic B, Hyde C, Trelle S, Weingart O, Brunskill S, Sandercock J, Seidenfeld J, Piper M, Langensiepen S, Schwarzer SG, Bennett C, Engert A.
    Epoetin and darbepoetin to treat cancer patients: updated meta-analysis results.
    Blood 2005, 106(11): Abstract No. 751.
    Access abstract: American Society of Hematology (ASH) abstracts online (freely available)